Drugs / Ad.p53-DC vaccines
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00617409 | Oct 2007 → Sep 2015 | small cell lung carcinoma | H. Lee Moffitt Cancer Center and Research Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad.p53-DC vaccines | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00617409 ↗ |
| Modality | Vaccine | “tumor (cancer) vaccine” NCT00617409 ↗ |
| Route | Other | “will be injected intradermally” NCT00617409 ↗ |